La tos ferina en el adolescente y el adulto. Epidemiología e implicaciones para la vacunación

Medicina Clinica

Volumn 114, Issue 17, 2000, Pages 661-664

  Campins Martí, Magda ^a,b   Moraga Llop, Fernando A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; CLINICAL FEATURE; HUMAN; IMMUNITY; IMMUNIZATION; PERTUSSIS; REVIEW; VACCINATION;

EID: 0034611880     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71394-7     Document Type: Article

References (45)

1. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174 (Supl 3): 259-263.
2. CDC. Pertussis surveillance. United States. 1989-91. JAMA 1993; 269: 1489-1498.
3. Farizo KM, Cochi SL, Zell ER, Brink E, Wassilack SGF, Patriarca PA. Epidemiologic features of pertussis in the United States, 1980-1089. Clin Infect Dis 1992; 14: 708-719.
4. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan, Public Health Rep 1965; 80: 365-369.
5. Long SS. Pertussis. En: Nelson WE, editor. Texbook of pediatrics, Filadelfia: Saunders, 1996; 779-784.
6. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997; 16: S85-S89.
7. a ed.). En: Plotkin SA, Orenstein WA, editores. Filadelfia: W.B. Saunders Company, 1999; 293-344.
8. CDC. Reported vaccine-preventable diseases: United States, 1993, and the Childhood Immunization Initiative. MMWR 1994; 43: 57-60.
9. CDC. Summary of notifiable diseases, United States, 1997. MMWR 1998; 46: 47-48.
10. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994; 13: 343-345.
11. Centro Nacional de Epidemiología. Comentario epidemiológico de las Enfermedades de Declaración Obligatoria y Sistema de Información Microbiológica. España. Año 1998. Bol Epidemiol Semanal 1999; 7: 1-5.
12. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672-1674.
13. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995; 171: 1650-1652.
14. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044-1046.
15. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection. Med J Aust 1987; 147: 522-525.
16. Schmitt-Grohe S, Cherry JD, Heininger U, Überall MA, Pineda E, Stehr K. Pertussis in German adults. Clin Infect Dis 1995; 21: 860-866.
17. Mink CM, Cherry JD, Christenson P. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14: 464-471.
18. Cramer BA, Goydos J, Hackell J, Mezzatesta J, Decker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child 1993; 147: 575-577.
19. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995; 346: 1326-1329.
20. Aoyama T, Takeuchi Y, Goto A, Iwai H, Murase Y, Iwata T. Pertussis in adults. Am J Dis Child 1992; 145: 163-166.
21. Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child 1978; 132: 371-377.
22. Storsaeter J, Blackwelder WC, Hallander HO. Pertussis antibodies, protection and vaccine efficacy after household exposure. Am J Dis Child 1992; 146: 167-172.
23. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161: 480-486.
24. Deen JL, Mink CA, Cherry JD. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21: 1211-1219.
25. Baron S, Njankepo E, Grimprel E, Begue P, Desenclos JC, Drucker J et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17: 412-418.
26. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infec Control Hosp Epidemiol 1999; 20: 120-123.
27. Ortega P, Gil A, Astasio P, Domínguez V, De Juanes JR, Arrazola P et al. Prevalencia de anticuerpos frente a tétanos, difteria y Bordetella pertussis en profesionales sanitarios. Enferm Infecc Microbiol Clin 1999; 17: 135-137.
28. Haiduven DJ, Hench CP, Simpkins SM, Stevens DA. Standardized management of patients and employees exposed to pertussis. Infect Control Hosp Epidemiol 1998; 19: 861-864.
29. Weber DJ, Rutala WA. Pertussis: an underappreciated risk for nosocomial outbreaks. Infect Control Hosp Epidemiol 1998; 19: 825-828.
30. Van Loo IHM, Van der Heide GJ, Nagelkerke NJD, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis 1999; 179: 915-923.
31. Clark AC, Bradford WL, Berry GP. An epidemiologicai study of an outbreak of pertussis in a public school. Am J Public Health 1946; 36: 1165-1162.
32. Jenkinson D. Duration and effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988; 296: 612-514.
33. Cody CL, Baraff LJ, Cherry JD. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68: 650-660.
34. Campins M. Vacunas de la tos ferina. En: Campins M, Moraga FA. editores. Vacunas 1997. Barcelona: Prous Science S.A., 1997; 13-27.
35. Decker MD, Edwards KM, Steinhoff MC. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995; 96 (Supl): 557-566.
36. CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR 1997; 46 (RR-7).
37. Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC. Comparison of 13 acellular pertussis vaccines: overview and serological response. Pediatrics 1995; 96 (Supl): 548-557.
38. Comité Asesor de Vacunas de la AEP.Calendario vacunal de la AEP 1999. An Esp Pediatr 1999; 51: 120-126.
39. Van Damme P, Joossens E, Vellinga A, Vanderwieten M, Ramalho A, Kaufhold A. A diphtheria-tetanus-acellular pertussis (dTpa) vaccine for adults. Clin Infect Dis 1998; 27: 1053.
40. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 1999; (Supl 2): 118-123.
41. Tran Minh NN, Edelman K, He Q, Viljanen MK, Arvilommi H, Mertsola J. Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children. Vaccine 1998; 16: 1604-1610.
42. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Diego, EE.UU., 24 de septiembre de 1998.
43. st Century. Atenas, 22-23 de octubre de 1998.
44. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin Infect Dis 1999; 28 (Supl 2): 147-150.
45. Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective rather than universal recommendations. Clin Infect Dis 1999; (Supl 2): 131-135.